Identifying new E3 Ubiquitin ligase ligands for new PROTACs design is a key element that can improve selective proteasomal-dependent degradation of proteins of interest involved in many pathological processes such as cancer, chronic anaemia, and ischemia.
Our fluorescent probe for VHL E3 ligase is a powerful tool both for compound screening for new E3ligase ligands and for PROTACs analysis
Showing all 4 results
Product on backorder. Contact us at info@celtarys.com for an estimated delivery date.
Product on backorder. Contact us at info@celtarys.com for an estimated delivery date.
Product on backorder. Contact us at info@celtarys.com for an estimated delivery date.
Product on backorder. Contact us at info@celtarys.com for an estimated delivery date.